COMMUNIQUÉS West-GlobeNewswire

Longeveron to Present at the Planet MicroCap Showcase

25/04/2024 - 22:05

MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will participate in the Planet MicroCap [...]

Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®

25/04/2024 - 22:05

CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product ROACTEMRA ® CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. ( [...]

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024

25/04/2024 - 22:05

Year-over-year revenue grows 7% , operating profit up 25% , non-GAAP operating profit up 23% Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at [...]

Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List

25/04/2024 - 22:05

SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, has been named on Newsweek’s list of The World’s Best Digital Health Companies [...]

Teladoc Health Reports First Quarter 2024 Results

25/04/2024 - 22:05

PURCHASE, NY, April 25, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended March 31, 2024 (“First [...]

Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024

25/04/2024 - 22:03

SEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 29, 2024. "Accolade has built a rare healthcare [...]

Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering

25/04/2024 - 22:01

PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]

Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants

25/04/2024 - 22:01

PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced a proposed underwritten public offering of shares of its common stock and accompanying common stock warrants to [...]

Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report

25/04/2024 - 20:00

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period [...]

Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel Chemically Diverse Macrocycles

25/04/2024 - 20:00

– Company creating de novo designed macrocycles with enhanced efficacy that precisely target disease biology – Vilya’s privileged macrocycles have the potential to be applied across broad therapeutic areas, addressing [...]

CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners

25/04/2024 - 19:30

CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners CARBIOS’ first plant is also a world first using revolutionary enzymatic depolymerization technology, marking a major [...]

CARBIOS pose la première pierre de son usine de biorecyclage du PET, une première mondiale, avec ses partenaires

25/04/2024 - 19:30

CARBIOS pose la première pierre de son usine de biorecyclage du PET, une première mondiale, avec ses partenaires Cette première usine de CARBIOS est aussi une première mondiale utilisant la technologie révolutionnaire [...]

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

25/04/2024 - 19:00

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – April 25, 2024 – 07:00 PM CET (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today [...]

Guerbet : Chiffre d’affaires du 1er trimestre 2024.

25/04/2024 - 17:45

Chiffre d’affaires du 1 er trimestre 2024 Activité trimestrielle Chiffre d’affaires : 194,3 M€, en hausse de 8,8% à TCC 1 Une croissance toujours particulièrement soutenue en Asie (+26,8% à TCC) et en zone Amériques (+ [...]

Guerbet : Q1 2024 revenue.

25/04/2024 - 17:45

Q1 2024 revenue Quarterly activity Revenue: €194.3m, up 8.8% at CER 1 Growth remains particularly strong in Asia (+26.8% at CER) and the Americas (+20.1% at CER); the EMEA region (-6.2% at CER) was temporarily impacted [...]

Ibogaine Treatment for Borderline Personality Disorder Launched by Ibogaine By David Dardashti

25/04/2024 - 16:54

New Protocol Developed to Provide Holistic, Compassionate Treatment MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce the launch of a unique therapy protocol designed to provide [...]

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

25/04/2024 - 16:44

HOUSTON, TEXAS, April 25, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market (“Nasdaq”) on April [...]

Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab

25/04/2024 - 16:00

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug [...]

RS BioTherapeutics Adds Jane Wright-Mitchell, Pharm.D., J.D. to Business Advisory Board

25/04/2024 - 16:00

Ms. Wright-Mitchell to serve as fractional General Counsel and Compliance Advisor CUMBERLAND, Md., April 25, 2024 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the [...]